Works matching IS 02704137 AND DT 2008 AND VI 68 AND IP 8

Results: 11

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.

Published in:

Prostate, 2008, v. 68, n. 8, p. 809, doi. 10.1002/pros.20742

By:

Wang, Wei;
Rayburn, Elizabeth R.;
Hao, Miao;
Zhao, Yuqing;
Hill, Donald L.;
Zhang, Ruiwen;
Wang, Hui

Publication type:

Article

Genetic changes and DNA damage responses in the prostate.

Published in:

Prostate, 2008, v. 68, n. 8, p. 902, doi. 10.1002/pros.20746

By:

Kiviharju-af Hällström, Taija M.;
Laiho, Marikki

Publication type:

Article

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.

Published in:

Prostate, 2008, v. 68, n. 8, p. 861, doi. 10.1002/pros.20752

By:

Morgan, Todd M.;
Pitts, Tiffany E.M.;
Gross, Ted S.;
Poliachik, Sandra L.;
Vessella, Robert L.;
Corey, Eva

Publication type:

Article

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

Published in:

Prostate, 2008, v. 68, n. 8, p. 839, doi. 10.1002/pros.20749

By:

Bao, Bo-Ying;
Chuang, Bin-Fay;
Wang, Qianben;
Sartor, Oliver;
Balk, Steven P.;
Brown, Myles;
Kantoff, Philip W.;
Lee, Gwo-Shu Mary

Publication type:

Article

Endothelial cells support the growth of prostate tissue in vivo.

Published in:

Prostate, 2008, v. 68, n. 8, p. 893, doi. 10.1002/pros.20762

By:

Bates, Michael;
Kovalenko, Bruce;
Wilson, E. Lynette;
Moscatelli, David

Publication type:

Article

RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.

Published in:

Prostate, 2008, v. 68, n. 8, p. 820, doi. 10.1002/pros.20744

By:

Ignatoski, K. M. Woods;
Escara-Wilke, J. F.;
Dai, J.-L.;
Lui, A.;
Dougall, W.;
Daignault, S.;
Yao, Z.;
Zhang, J.;
Day, M. L.;
Sargent, E. E.;
Keller, E. T.

Publication type:

Article

Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.

Published in:

Prostate, 2008, v. 68, n. 8, p. 872, doi. 10.1002/pros.20755

By:

Fujita, Kazutoshi;
Ewing, Charles M.;
Sokoll, Lori J.;
Elliott, Debra J.;
Cunningham, Mark;
De Marzo, Angelo M.;
Isaacs, William B.;
Pavlovich, Christian P.

Publication type:

Article

In vivo and in vitro studies of anticancer actions of α-TEA for human prostate cancer cells.

Published in:

Prostate, 2008, v. 68, n. 8, p. 849, doi. 10.1002/pros.20750

By:

Jia, Li;
Yu, Weiping;
Wang, Pei;
Sanders, Bob G.;
Kline, Kimberly

Publication type:

Article

Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.

Published in:

Prostate, 2008, v. 68, n. 8, p. 803, doi. 10.1002/pros.20743

By:

Cho, Kang Su;
Lee, Joong Shik;
Cho, Nam Hoon;
Park, Kyeongmee;
Ham, Won Sik;
Choi, Young Deuk

Publication type:

Article

Elevated levels of HER-2/ neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.

Published in:

Prostate, 2008, v. 68, n. 8, p. 830, doi. 10.1002/pros.20747

By:

Ricciardelli, Carmela;
Jackson, Michael W.;
Choong, Catherine S.;
Stahl, Jürgen;
Marshall, Villis R.;
Horsfall, David J.;
Tilley, Wayne D.

Publication type:

Article

Characterization of PacMetUT1, a recently isolated human prostate cancer cell line.

Published in:

Prostate, 2008, v. 68, n. 8, p. 883, doi. 10.1002/pros.20758

By:

Troyer, D.A.;
Tang, Y.;
Bedolla, R.;
Adhvaryu, S.G.;
Thompson, I.M.;
Abboud-Werner, S.;
Sun, L.-Z.;
Friedrichs, W.E.;
deGraffenried, L.A.

Publication type:

Article